Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

QuantumRD demonstration to Chevron

14 Mar 2012 07:00

RNS Number : 2422Z
ViaLogy PLC
14 March 2012
 



 

 

ViaLogy PLC ("ViaLogy" or "the Company")

 

ViaLogy Delivers Novel Technology to Chevron

 

London, March 14, 2012. ViaLogy PLC (VIY) announces it has completed a key demonstration project of its QuantumRD technology under contract with Chevron U.S.A. Inc. Working closely with Chevron geophysicists, ViaLogy successfully applied QuantumRD to a 3D seismic data set for the purpose of delineating the porosity trends in the tight dolomites of the lower Permian Basin.

 

Variations in carbonates with low porosity have extremely small expression in the seismic response buried below background noise in the data and previous attempts to discriminate had not been successful. The QuantumRD workflow processes events down to signal amplitudes below -24dB to assess how coherent and random noise within the full seismic acquisition spectrum is differentially and directly modulated by subtle changes in porosity. Unlike conventional signal processing, QuantumRD uses a synthetic noise source, designed using rock-physics and well-control data to probe the acquired seismic data and to detect, characterize and amplify changes in seismic noise. This process of excitation of conventionally acquired seismic data using synthetic noise in software, determines attributes of interest, such as presence of pre-specified levels of porosity, as emergent quantum resonances. In less technical terms, ViaLogy points out that QuantumRD was able to discern porosity, a key rock property in locating and identifying hydrocarbon deposits, where other techniques have not. The significance of this is that it could bring a new level of accuracy and predictive capability to hydrocarbon reservoir characterization.

 

Sandeep Gulati, ViaLogy's VP for Product Development and CTO, states "QuantumRD produced an attribute for predicting porosity 2 to 3 miles away from existing wells, something considered extremely difficult for this type of formation. Such predictions at the vertical intervals used represent a twofold increase over conventional seismic interpretation resolution. One project conclusion is that utilizing this method could result in significant reduction of the wells actually needed to extract oil over current standard gridding techniques, while increasing recovery from optimally placed wells based on QuantumRD analysis."

 

ViaLogy's CEO Robert Dean commented, "Putting our technology to use on behalf of another of the world's leading oil companies has given ViaLogy the opportunity to show that it could solve some of the key extraction problems facing the industry today, and that it holds the promise of helping E&P firms avoid risks and saving considerable capital expenditure costs, and -in an era of increasing demand for gas and oil - could serve as a valuable tool for further and more efficient production from fields that have thus far proven to be uneconomic. We look forward to continuing our work with Chevron under our existing contract with them."

 

For further information contact: 

ViaLogy Plc

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy / Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner, Corporate Broking +44 (0) 20-7107-8000

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBXLFFLXFEBBQ
Date   Source Headline
1st Apr 201912:12 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSYourgene raises IONA® test awareness in Egypt
26th Feb 20193:21 pmRNSHolding(s) in Company
22nd Feb 201910:00 amEQSHardman & Co Research: Yourgene Health (YGEN): EBITDA-positive in fiscal 2020
22nd Feb 20198:05 amRNSHolding(s) in Company
19th Feb 20192:21 pmRNSHolding(s) in Company
19th Feb 20197:15 amEQSHardman & Co Research: Yourgene Health (YGEN): Transformed and de-risked
18th Feb 201910:59 amRNSIssue of Equity
18th Feb 20197:00 amRNSMajor Capital & Commercial Restructuring
8th Jan 20197:00 amRNSYourgene launches Sage 32 plex
3rd Dec 20187:00 amRNSHalf-year Results
7th Nov 20187:00 amRNSChange of Name to Yourgene Health plc
5th Nov 201811:24 amRNSShare Transfer
2nd Nov 20187:00 amRNSDirectorate Change
25th Oct 20183:30 pmRNSResult of AGM
25th Oct 20187:00 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSAGM Statement
22nd Oct 20187:00 amRNSFurther re: Fundraise
12th Oct 20181:15 pmRNSAvailability of Research Commentary
12th Oct 20187:00 amRNSTrading Update and Notice of Results
5th Oct 20187:00 amRNSDirector's dealing and share option issue
4th Oct 20187:00 amRNS$1 million collaboration agreement
3rd Oct 20187:00 amRNSDirectorate change
2nd Oct 20187:00 amRNSNotice of AGM
1st Oct 201812:20 pmRNSResult of Fundraise
28th Sep 20185:41 pmRNSProposed fundraise to raise approximately £2.5m
28th Sep 20185:40 pmRNSFull year results and half-year trading update
25th Sep 201811:31 amRNSHolding(s) in Company
21st Sep 20184:10 pmRNSHolding(s) in Company
21st Sep 20187:00 amRNSHolding(s) in Company
20th Sep 20189:30 amRNSSenior Appointment & Anticipated Director Change
19th Sep 201811:05 amRNSSecond Price Monitoring Extn
19th Sep 201811:00 amRNSPrice Monitoring Extension
19th Sep 20187:00 amRNSLegal Settlement & Licence Agreement with Illumina
11th Sep 20187:00 amRNSHolding(s) in Company
7th Aug 201810:57 amRNSHolding(s) in Company
12th Jul 20187:00 amRNSShare option awards
4th Jul 20187:00 amRNSBoard Changes
26th Jun 20181:31 pmRNSCollaboration with Abnova
13th Jun 20187:00 amRNSOutstanding NIPS Solution Provider Award Win
11th Jun 20187:00 amRNSDNA sequencing technology development agreement
7th Jun 20183:44 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSPremaitha signs partnership agreement in India
4th Jun 201811:05 amRNSHolding(s) in Company
24th May 20187:00 amRNSHolding(s) in Company
18th May 20184:38 pmRNSHolding(s) in Company
18th May 201812:06 pmRNSHolding(s) in Company
18th May 201812:05 pmRNSHolding(s) in Company
18th May 20189:40 amRNSHoldings in Company
15th May 20187:00 amRNSPremaitha expands footprint with new laboratories

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.